Literature DB >> 23456291

Centenary of Lewy bodies (1912-2012).

Bernd Holdorff1, Antonio M Rodrigues e Silva, Richard Dodel.   

Abstract

During the years from 1908 until 1923, Lewy was the first to detail the pathological anatomy of Parkinson's disease, leading to his seminal contribution in 1912 describing the neuronal eosinophilic cytoplasmatic concentric inclusion bodies in the brainstem, later accomplished by more systematic investigations in 1923 (Lewy in Lewandowsky's Handbuch der Neurologie, 3. Band: Spez. Neurologie II. Springer, Berlin, pp 920-933, 1912). With the exception of a minority of cases and those that displayed postencephalitic Parkinsonism, Lewy was not able to confirm the significance of the substantia nigra. The findings of Tretiakoff in 1919 (significance of the substantia nigra in PD and coining of the term 'Corps de Lewy') have been underestimated or ignored for a long time. In a historical review on basal ganglia diseases from 1942, Lewy stressed the histological abnormalities of the basal ganglia and their diffuse distribution but not expressly the inclusion bodies, which in his former studies were unique in PD. For Lewy this finding was not a characteristic of the disease. Subsequent to his expulsion from Nazi-Germany in 1933, Lewy never resumed his research on PD. At the time of Lewy's death in 1950, the era of the Lewy bodies, Lewy-body-disease and the identification of atypical Parkinson syndrome cases had not even begun and followed much later.

Entities:  

Mesh:

Year:  2013        PMID: 23456291     DOI: 10.1007/s00702-013-0984-2

Source DB:  PubMed          Journal:  J Neural Transm (Vienna)        ISSN: 0300-9564            Impact factor:   3.575


  12 in total

Review 1.  Staging of the intracerebral inclusion body pathology associated with idiopathic Parkinson's disease (preclinical and clinical stages).

Authors:  Heiko Braak; Kelly Del Tredici; Hansjürgen Bratzke; John Hamm-Clement; Daniele Sandmann-Keil; Udo Rüb
Journal:  J Neurol       Date:  2002-10       Impact factor: 4.849

2.  The brain-stem lesions in Parkinsonism.

Authors:  J G GREENFIELD; F D BOSANQUET
Journal:  J Neurol Neurosurg Psychiatry       Date:  1953-11       Impact factor: 10.154

3.  Fritz Heinrich Lewy (1885-1950).

Authors:  Bernd Holdorff
Journal:  J Neurol       Date:  2006-05       Impact factor: 4.849

4.  The black stuff and Konstantin Nikolaevich Tretiakoff.

Authors:  Andrew J Lees; Marianna Selikhova; Luiz Augusto Andrade; Charles Duyckaerts
Journal:  Mov Disord       Date:  2008-04-30       Impact factor: 10.338

5.  Alpha-synuclein in Lewy bodies.

Authors:  M G Spillantini; M L Schmidt; V M Lee; J Q Trojanowski; R Jakes; M Goedert
Journal:  Nature       Date:  1997-08-28       Impact factor: 49.962

6.  What's in a name? Dr. Lewey and the Lewy body.

Authors:  P J Sweeney; M F Lloyd; R B Daroff
Journal:  Neurology       Date:  1997-08       Impact factor: 9.910

7.  alpha-Synuclein in filamentous inclusions of Lewy bodies from Parkinson's disease and dementia with lewy bodies.

Authors:  M G Spillantini; R A Crowther; R Jakes; M Hasegawa; M Goedert
Journal:  Proc Natl Acad Sci U S A       Date:  1998-05-26       Impact factor: 11.205

Review 8.  The centenary of Friederich H. Lewy 1885-1950.

Authors:  W R Gibb; W H Poewe
Journal:  Neuropathol Appl Neurobiol       Date:  1986 May-Jun       Impact factor: 8.090

9.  Friedrich Heinrich Lewy (1885-1950) and his work.

Authors:  Bernd Holdorff
Journal:  J Hist Neurosci       Date:  2002-03       Impact factor: 0.529

Review 10.  Stanley Fahn Lecture 2005: The staging procedure for the inclusion body pathology associated with sporadic Parkinson's disease reconsidered.

Authors:  Heiko Braak; Jürgen R Bohl; Christian M Müller; Udo Rüb; Rob A I de Vos; Kelly Del Tredici
Journal:  Mov Disord       Date:  2006-12       Impact factor: 10.338

View more
  10 in total

Review 1.  α-Synuclein in Parkinson's disease: causal or bystander?

Authors:  Peter Riederer; Daniela Berg; Nicolas Casadei; Fubo Cheng; Joseph Classen; Christian Dresel; Wolfgang Jost; Rejko Krüger; Thomas Müller; Heinz Reichmann; Olaf Rieß; Alexander Storch; Sabrina Strobel; Thilo van Eimeren; Hans-Ullrich Völker; Jürgen Winkler; Konstanze F Winklhofer; Ullrich Wüllner; Friederike Zunke; Camelia-Maria Monoranu
Journal:  J Neural Transm (Vienna)       Date:  2019-06-25       Impact factor: 3.575

Review 2.  [Persecuted and forgotten? The neurologists Kurt Goldstein and Friedrich Heinrich Lewy].

Authors:  Michael Martin; Heiner Fangerau; Axel Karenberg
Journal:  Nervenarzt       Date:  2022-10-05       Impact factor: 1.297

Review 3.  Insights Into the Role of Mortalin in Alzheimer's Disease, Parkinson's Disease, and HIV-1-Associated Neurocognitive Disorders.

Authors:  Pankaj Seth
Journal:  Front Cell Dev Biol       Date:  2022-07-04

4.  Whole Clinic Research Enrollment in Parkinson's Disease: The Molecular Integration in Neurological Diagnosis (MIND) Study.

Authors:  Thomas F Tropea; Noor Amari; Noah Han; Jacqueline Rick; EunRan Suh; Rizwan S Akhtar; Nabila Dahodwala; Andres Deik; Pedro Gonzalez-Alegre; Howard Hurtig; Andrew Siderowf; Meredith Spindler; Matthew Stern; Mary Ann Thenganatt; Daniel Weintraub; Allison W Willis; Vivianna Van Deerlin; Alice Chen-Plotkin
Journal:  J Parkinsons Dis       Date:  2021       Impact factor: 5.568

Review 5.  Parkinson's disease and mitophagy: an emerging role for LRRK2.

Authors:  Francois Singh; Ian G Ganley
Journal:  Biochem Soc Trans       Date:  2021-04-30       Impact factor: 5.407

6.  Passiflora cincinnata Extract Delays the Development of Motor Signs and Prevents Dopaminergic Loss in a Mice Model of Parkinson's Disease.

Authors:  Luiz Eduardo Mateus Brandão; Diana Aline Morais Ferreira Nôga; Aline Lima Dierschnabel; Clarissa Loureiro das Chagas Campêlo; Ywlliane da Silva Rodrigues Meurer; Ramón Hypolito Lima; Rovena Clara Galvão Januário Engelberth; Jeferson Souza Cavalcante; Clésio Andrade Lima; Murilo Marchioro; Charles Dos Santos Estevam; José Ronaldo Santos; Regina Helena Silva; Alessandra Mussi Ribeiro
Journal:  Evid Based Complement Alternat Med       Date:  2017-08-01       Impact factor: 2.629

7.  Biological bases for a possible effect of cannabidiol in Parkinson's disease.

Authors:  Nilson C Ferreira-Junior; Alline C Campos; Francisco S Guimarães; Elaine Del-Bel; Patrícia M da R Zimmermann; Liberato Brum Junior; Jaime E Hallak; José A Crippa; Antonio W Zuardi
Journal:  Braz J Psychiatry       Date:  2019-07-15       Impact factor: 2.697

Review 8.  Parkinson's disease and translational research.

Authors:  Elisabeth Dinter; Theodora Saridaki; Leonie Diederichs; Heinz Reichmann; Björn H Falkenburger
Journal:  Transl Neurodegener       Date:  2020-12-01       Impact factor: 8.014

Review 9.  Pathology and function of nuclear amyloid. Protein homeostasis matters.

Authors:  Anna von Mikecz
Journal:  Nucleus       Date:  2014 Jul-Aug       Impact factor: 4.197

10.  Lewy and his inclusion bodies: Discovery and rejection.

Authors:  Eliasz Engelhardt; Marleide da Mota Gomes
Journal:  Dement Neuropsychol       Date:  2017 Apr-Jun
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.